Shanghai Rendu Biotechnology Co

Shanghai Rendu Biotechnology Co Rule of 40

The Rule of 40 of Shanghai Rendu Biotechnology Co (688193.SS) as of Oct 14, 2026 is -17.50 %. In the previous year, Rule of 40 was 1.05 % — a change of -1,765.98% (lower).

Rule of 40

-17.50 %

YoY

-1,765.98%

Last updated:

Rule of 40 of Shanghai Rendu Biotechnology Co is 2025 -17.50 % . Rule of 40 of Shanghai Rendu Biotechnology Co was 2024 1.05 % . It decreases by -1,765.98% lower compared to the previous year.

The Shanghai Rendu Biotechnology Co Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2019
46.44 CNY
Jan 1, 2020
179.50 CNY
Jan 1, 2021
40.93 CNY
Jan 1, 2022
10.18 CNY
Jan 1, 2023
-50.95 CNY
Jan 1, 2024
1.05 CNY
Jan 1, 2025
-17.50 CNY
The Shanghai Rendu Biotechnology Co Rule of 40 history
YEARRule of 40YoY
-17.50 %-1,765.98%
1.05 %-102.06%
-50.95 %-600.29%
10.18 %-75.12%
40.93 %-77.20%
179.50 %+286.52%
46.44 %—
Access this data via the Eulerpool API

Shanghai Rendu Biotechnology Co Stock analysis

What does Shanghai Rendu Biotechnology Co do? Shanghai Rendu Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Rendu Biotechnology Co stock

Rule of 40 of Shanghai Rendu Biotechnology Co is -17.50 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Shanghai Rendu Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

Quality — Shanghai Rendu Biotechnology Co

All Key Metrics — Shanghai Rendu Biotechnology Co